Details for 2011806079

Up to date per 01.04.2026

Actions

Title / Product Name

KRISTALLINE FORMEN VON 5-CHLORO-N2- (2-ISOPROPOXY-5-METHYL-4-PIPERIDIN-4-YL-PHENYL) -N4 [2- (PROPAN-2-SULFONYL) -PHENYL] -PYRIMIDIN-2,4-DIAMIN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2011806079

EP Publication Number

2651918

E-Number

908188

Language

PCT Number

US11065030

Publication Date

23.10.2013 A

12.07.2017 B1

Registration Date

12.07.2017

AT Publication Date

15.07.2017

Application Date

15.12.2011

Registration Number

Priorities

17.12.2010

201061424194 P

IPC

C07D 401/12 20060101AFI20120705BHEP

Maximum Duration of Protection

15.12.2031

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

SCHWARZ & PARTNER PATENTANWÄLTE OGWipplingerstraße 301010 WienAT

Inventor

FENG, LiliNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US

GONG, BaoqingNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US

KARPINSKI, Piotr H.Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US

WAYKOLE, Liladhar MurlidharNovartis Pharmaceuticals Corporation One Health Plaza East Hanover, New Jersey 07936-1080US